|
|||||
|
|
| 甲状腺未分化癌的综合治疗 | |
| 引用本文： | 殷德涛,张朋宇. 甲状腺未分化癌的综合治疗[J]. 肿瘤防治研究, 2022, 49(2): 85-89. DOI: 10.3971/j.issn.1000-8578.2022.21.1276 |
| 作者姓名： | 殷德涛 张朋宇 |
| 作者单位： | 450052 郑州，郑州大学第一附属医院甲状腺外科 |
| 基金项目： | 河南省中医药研究重大专项(20-21ZYZD14);河南省中青年科技创新领军人才项目(YXKC2020015)。 |
| 摘 要： | 甲状腺未分化癌（ATC）是一种罕见的肿瘤，占甲状腺癌的1%~2%，其死亡病例占甲状腺癌致死病例的大多数。目前，主要采用的治疗方式包括手术、放疗、化疗、靶向治疗和免疫治疗。本文根据最新的美国甲状腺学会（ATA）指南和近年相关文献，阐述ATC的综合治疗方式以提高ATC患者的生存率和生活质量 |
| 关 键 词： | 甲状腺未分化癌（ATC） 手术治疗 放化疗 免疫治疗 靶向治疗 |
| 收稿时间： | 2021-11-05 |
Comprehensive Treatment of Anaplastic Thyroid Cancer |
|
| YIN Detao,ZHANG Pengyu. Comprehensive Treatment of Anaplastic Thyroid Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(2): 85-89. DOI: 10.3971/j.issn.1000-8578.2022.21.1276 | |
| Authors: | YIN Detao ZHANG Pengyu |
| Affiliation: | Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China |
| Abstract: | Anaplastic thyroid cancer (ATC) is a rare malignancy,accounting for 1%-2% of all thyroid cancers,however,ATC accounts for the majority of deaths from thyroid cancer.Currently,the main comprehensive treatments are surgery,radiotherapy,chemotherapy,targeted therapy and immunotherapy.Based on the latest American Thyroid Association guidelines and the related literatures,we summarize the most reasonable and effective therapeutic strategies to improve the survival rate of patients with ATC as well as the quality of life. |
| Keywords: | Anaplastic thyroid cancer Surgery Chemoradiotherapy Immunotherapy Targeted therapy |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《肿瘤防治研究》浏览原始摘要信息 | |
| 点击此处可从《肿瘤防治研究》下载全文 | |